Femasys Inc. Provides Strategic Update on its FemaSeed® Pivotal Trial Design to Expedite Clinical Program Advancement Media / By lsc-webmaster
Femasys Inc. Announces the Appointment of Christine Thomas as Senior Vice President of Regulatory and Clinical Affairs Media / By lsc-webmaster
Femasys Inc. Announces Enrollment Completion for Stage 2 Study of FemBloc for Permanent Birth Control Media / By lsc-webmaster
Femasys Inc. Announces the Commercial Availability of FemCerv® for Cervical Cancer Screening and Expands Management Team Media / By lsc-webmaster
Femasys innovating women’s reproductive health with minimally invasive, in-office technologies Media / By lsc-webmaster
